What people talked about at London Life Sciences Week

The week has exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated conversations about the direction of the country's life sciences sector.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

NHS updates outdated IP rules in bid to revive UK life sciences

20 November 2025 The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader.

Europe

As investment in UK life sciences wanes, is the sector in trouble?

14 October 2025 As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP.

Europe

UK govt sets sights on being AI drug discovery ‘world leader’

13 June 2025 Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.

More features

NHS updates outdated IP rules in bid to revive UK life sciences

MSD wins full sweep in world’s best-selling drug clash

Report reveals surge of AI adoption in IP but lawyers remain cautious

INTA votes in new 2026 president at Florida leadership meeting

Sandoz wins Fed Circ reversal of $39m hair loss patent verdict

Perkins Coie and Ashurst to merge into $2.7bn revenue firm

Sanofi unit defends booster vaccine trademark in Europe

Pillsbury bags first-chair litigator and inventor with ‘business acumen’

What people talked about at London Life Sciences Week

More on this story

Editor's picks

Editor's picks

More features